Derma Sciences (DSCI) Reports Q3 Loss of $0.08, Sales Fall Short
Tweet
Share
E-mailGet Alerts DSCI Hot Sheet
Price: $7.00 --0%
Financial Fact:
Total other expense: -230.57K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total other expense: -230.57K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Derma Sciences (NASDAQ: DSCI) reported Q3 EPS of ($0.08), $0.03 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $15.8 million versus the consensus estimate of $16.21 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Movano (MOVE) Misses Q2 EPS by 195c
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
